Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
Condition:   Actinic Keratosis Intervention:   Drug: lindamycin phosphate and benzoyl peroxide 1.2%/3.75% combination Sponsors:   Icahn School of Medicine at Mount Sinai;   Valeant Pharmaceuticals International, Inc. Recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2017 Category: Research Source Type: clinical trials